Improving follow-up care for lung cancer survivors
Official title: Toward an Integrated Approach to Assessing and Addressing Follow-Up Care Needs That Will Facilitate Care Transitions for Cancer Survivors: A Pilot Study
Run by Wake Forest University Health Sciences · NCT06654245 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing a new support program for lung cancer survivors to see if working with a navigator to create a personalized care plan helps them get better follow-up care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 15 (estimated) |
| Sponsor | Wake Forest University Health Sciences Academic / other |
| Locations | 1 site (Winston-Salem, North Carolina) |
| Trial ID | NCT06654245 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older who have been diagnosed with stage I to IV lung cancer within the last two years.
✕Probably not a fit
Patients who do not have a confirmed diagnosis of lung cancer or those who are unable to understand and participate in the intervention may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the effectiveness of a shared response plan called SHAREDCare in enhancing follow-up care for lung cancer survivors. The approach involves patients working with a navigator to identify their distress and social needs, followed by the development of a personalized care plan. The study includes qualitative assessments through interviews and quantitative measures to evaluate the acceptability and feasibility of the intervention. Patients will receive follow-up calls to ensure their needs are being met and to track any referrals made as a result of the intervention.
Why it matters
Potential benefit: If successful, this approach could significantly improve the quality of follow-up care for lung cancer survivors, addressing their specific needs more effectively.
How similar studies have gone: Other studies have shown promise in using personalized care plans and navigators to improve patient outcomes, suggesting that this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients must have histologically or cytologically confirmed study disease. A pathology report should be referenced/available (stages I-IV lung cancer) * Ability to understand and the willingness to sign an institutional review board (IRB)-approved informed consent document * ≥ 18 years of age * Within two years of lung cancer diagnosis * Able to understand, read and write English Exclusion Criteria: Does not meet the above inclusion criteria
Where it's running
-
Atrium Health Wake Forest Baptist Comprehensive Cancer Center (AH-WFBCCC)
Winston-Salem, North Carolina, United States Recruiting
Study contacts
- Study coordinator: Sarah Birken, PhD
- Email: sbirken@wakehealth.edu
- Phone: 919-357-2662
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Microwave ablation for treating lung cancer nodules
This study is testing a new microwave treatment for destroying small lung cancer nodules to see if it is safe and effective for patients.
-
Precise Exercise Regimen for Cancer Care: a small pilot in stage II/III NSCLC
This pilot tests the PERCC exercise program to see if it’s feasible for adults with stage II–III non-small cell lung cancer who are planned for neoadjuvant therapy and surgery.
-
Inhaled cisplatin for treating advanced lung cancer
This study is testing if inhaling a new form of chemotherapy can help people with advanced lung cancer live longer and feel better while reducing side effects from traditional treatments.
-
Postoperative radiotherapy after chemo-immunotherapy and surgery for stage III non-small cell lung cancer
This study tests whether adding postoperative radiotherapy to the involved lymph node regions helps people with stage III non-small cell lung cancer who still have cancer in their lymph nodes after neoadjuvant chemo-immunotherapy and surgery.
-
Combining total body irradiation with chemotherapy and immunotherapy for extensive stage lung cancer
This study is testing if adding total body radiation to standard chemotherapy and immunotherapy can help people with advanced small cell lung cancer live longer and feel better.
-
Combining adaptive radiation therapy with immunotherapy for advanced lung cancer treatment
This study is testing a new way of giving radiation therapy along with immunotherapy to see if it helps people with advanced lung cancer feel better and live longer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.